JPH07502036A - 新規な配合 - Google Patents
新規な配合Info
- Publication number
- JPH07502036A JPH07502036A JP5510585A JP51058593A JPH07502036A JP H07502036 A JPH07502036 A JP H07502036A JP 5510585 A JP5510585 A JP 5510585A JP 51058593 A JP51058593 A JP 51058593A JP H07502036 A JPH07502036 A JP H07502036A
- Authority
- JP
- Japan
- Prior art keywords
- budesonide
- inhalation
- separately
- treatment
- physiologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Tobacco Products (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Control Of Positive-Displacement Air Blowers (AREA)
- Fats And Perfumes (AREA)
- Heat Treatment Of Sheet Steel (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Edible Oils And Fats (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
- 1.呼吸器疾患の処置に際し同時に、連続的にまたは別個に吸入によって投与す るための、(i)フォルモテロール(および/またはその化理的に許容される塩 および/または溶媒和化合物)と(ii)ブデソニドを別個にまたは一緒に含有 する医薬。
- 2.呼吸器疾患の処置に際し吸入によって投与するための組成物おいて、フォル モテロール(および/またはその生理的に許容される塩および/または溶媒和化 合物)とブデソニドからなる医薬組成物。
- 3.呼吸器疾患の処置に際し同時に、連続的にまたは別個に吸入によって投与す るための配合製剤としての、フォルモテロール(および/またはその生理的に許 容される塩および/または溶媒和化合物)とブデソニドの有効量からなる医薬組 成物。
- 4.呼吸器疾患の処置に際し同時に、連続的にまたは別個に吸入によって投与す る併用療法に使用するための、フォルモテロール(および/またはその生理的に 許容される塩および/または溶媒和化合物)およびブデソニド。
- 5.呼吸器疾患の処置に際しフォルモテロール(および/またはその生理的に許 容される塩および/または溶媒和化合物)とブデソニドを、同時に、連続的にま たは別個に吸入によって投与する併用療法用の医薬の製造におけるフォルモテロ ール(および/またはその生理的に許容される塩および/または溶媒和化合物) の使用。
- 6.呼吸器疾患の処置に際しフォルモテロール(および/またはその生理的に許 容される塩および/または溶媒和化合物)とブデソニドを、同時に、連続的にま たは別個に吸入によって投与する併用療法用の医薬の製造におけるブデソニドの 使用。
- 7.呼吸器疾患の処置に際しフォルモテロールとブデソニドを、同時に、連続的 にまたは別個に吸入によって投与する併用療法用の医薬の製造におけるフォルモ テロール(および/またはその生理的に許容される塩および/または溶媒和化合 物)およびプデソニドの使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91311761.0 | 1991-12-18 | ||
EP91311761 | 1991-12-18 | ||
PCT/EP1992/002826 WO1993011773A1 (en) | 1991-12-18 | 1992-12-07 | New combination of formoterol and budesonide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07502036A true JPH07502036A (ja) | 1995-03-02 |
JP3342484B2 JP3342484B2 (ja) | 2002-11-11 |
Family
ID=8208509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51058593A Expired - Lifetime JP3342484B2 (ja) | 1991-12-18 | 1992-12-07 | 新規な配合 |
Country Status (21)
Country | Link |
---|---|
US (2) | US5674860A (ja) |
JP (1) | JP3342484B2 (ja) |
AT (1) | ATE213946T1 (ja) |
AU (1) | AU673660C (ja) |
CA (2) | CA2123909C (ja) |
CZ (2) | CZ288032B6 (ja) |
DE (2) | DE10299033I2 (ja) |
DK (1) | DK0613371T3 (ja) |
ES (1) | ES2172510T3 (ja) |
HK (1) | HK1010339A1 (ja) |
HR (1) | HRP921445B1 (ja) |
HU (2) | HU227519B1 (ja) |
IS (1) | IS3959A (ja) |
NO (2) | NO306452B1 (ja) |
NZ (1) | NZ246050A (ja) |
PT (1) | PT613371E (ja) |
SG (1) | SG48301A1 (ja) |
SI (1) | SI9200403B (ja) |
SK (2) | SK282826B6 (ja) |
WO (1) | WO1993011773A1 (ja) |
YU (1) | YU49083B (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002532418A (ja) * | 1998-12-18 | 2002-10-02 | ベーカー ノートン ファーマシューティカルズ インコーポレイテッド | フルオロアルカン、ブデソニド及びホルモテロールを含有する医薬用エアゾール製剤 |
JP2002537249A (ja) * | 1999-02-18 | 2002-11-05 | ノバルティス アクチエンゲゼルシャフト | 喘息のためのホルモテロールおよびプロピオン酸フルチカゾンの組み合わせ |
JP2010001295A (ja) * | 1999-03-03 | 2010-01-07 | Novartis Ag | 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ |
JP2019500340A (ja) * | 2015-12-04 | 2019-01-10 | メキシケム フロー エセ・ア・デ・セ・ヴェ | 薬学的組成物 |
KR20210108500A (ko) * | 2013-12-09 | 2021-09-02 | 파르마헤미이 베이.베이. | 건조 분말 흡입기 |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9410222D0 (en) * | 1994-05-21 | 1994-07-06 | Glaxo Wellcome Australia Ltd | Medicaments |
US5980949A (en) * | 1994-10-03 | 1999-11-09 | Astra Aktiebolag | Formulation for inhalation |
US5983956A (en) | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
SE9700134D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US5863910A (en) * | 1996-01-12 | 1999-01-26 | Bolonick; Joel | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
SE9603669D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
EP0969816B1 (en) * | 1997-03-20 | 2004-12-15 | Schering Corporation | Preparation of powder agglomerates |
SE9701956D0 (sv) * | 1997-05-23 | 1997-05-23 | Astra Ab | New composition of matter |
IL133597A0 (en) * | 1997-06-27 | 2001-04-30 | Astra Ab | New combination of antiasthma medicaments |
AU766637B2 (en) * | 1997-09-19 | 2003-10-23 | Astrazeneca Ab | New use for budesonide and formoterol |
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
KR20010040646A (ko) * | 1998-02-09 | 2001-05-15 | 블로닉, 조엘 | 위장관의 만성 염증성 질환의 치료방법 |
AU762246B2 (en) * | 1998-02-11 | 2003-06-19 | Rtp Pharma Corporation | Method and composition for treatment of inflammatory conditions |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
US6423298B2 (en) * | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
DE19847969A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
US6235725B1 (en) * | 1998-10-30 | 2001-05-22 | Baker Norton Pharmaceuticals, Inc. | Methods and compositions for the prevention of tolerance to medications |
CA2347856C (en) | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
US20040002548A1 (en) * | 1999-05-12 | 2004-01-01 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
US20100197719A1 (en) * | 1999-05-12 | 2010-08-05 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
US7226934B1 (en) * | 1999-09-13 | 2007-06-05 | Bridge Pharma, Inc. | Optically active isomers of ketotifen and therapeutically active metabolites thereof |
GB9928311D0 (en) * | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
CO5251465A1 (es) * | 2000-01-26 | 2003-02-28 | Pfizer Prod Inc | Composiciones y procedimientos para tratar la osteoporosis y reducir el colesterol |
US6369115B1 (en) | 2000-03-20 | 2002-04-09 | Dura Pharmaceuticals, Inc. | Stabilized powder formulations |
CA2405599A1 (en) * | 2000-04-13 | 2001-10-25 | Innovata Biomed Limited | Medicaments for treating respiratory disorders comprising formoterol and fluticasone |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
GB0012261D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
FI20002215A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US6701921B2 (en) | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
ITMI20010428A1 (it) * | 2001-03-02 | 2002-09-02 | Chemo Breath S A | Composizioni ad uso inalatorio a base di formoterolo |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
AU2002303425A1 (en) * | 2001-04-24 | 2002-11-05 | Epigenesis Pharmaceuticals, Inc. | Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
ATE401058T1 (de) | 2001-11-01 | 2008-08-15 | Nektar Therapeutics | Sprühtrocknungsverfahren |
US20030229058A1 (en) * | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
GB0129260D0 (en) * | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
US6804458B2 (en) | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
US20050009798A1 (en) | 2002-02-20 | 2005-01-13 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
GB0219512D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions with high drug ratios |
GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
WO2004028545A1 (en) * | 2002-09-25 | 2004-04-08 | Astrazeneca Ab | A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
SE0203376D0 (sv) * | 2002-11-15 | 2002-11-15 | Astrazeneca Ab | New process |
EP1572217B1 (en) | 2002-12-12 | 2008-08-20 | Nycomed GmbH | Combination medicament of r,r-formoterol and ciclesonide |
US7311790B2 (en) * | 2003-04-25 | 2007-12-25 | Siemens Power Generation, Inc. | Hybrid structure using ceramic tiles and method of manufacture |
SE526850C2 (sv) * | 2003-06-19 | 2005-11-08 | Microdrug Ag | Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd |
SE527069C2 (sv) | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
SE526509C2 (sv) * | 2003-06-19 | 2005-09-27 | Microdrug Ag | Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd |
SE527200C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av formaterol och fluticason |
SE527189C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel |
SE527190C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
CA2534934A1 (en) | 2003-08-06 | 2005-02-17 | Galephar M/F | Advantageous combinations for inhalation of nacystelyn and bronchodilators |
TWI341836B (en) | 2004-03-11 | 2011-05-11 | Theravance Inc | Biphenyl compounds useful as muscarinic receptor antagonists |
DE602005023690D1 (de) | 2004-07-16 | 2010-11-04 | Almirall Sa | Inhalator für die Abgabe von pharmzeutischen Pulver, und ein Pulverkassette zur Verwendung mit diesem Inhalator |
US8337815B2 (en) * | 2004-12-23 | 2012-12-25 | Discovery Laboratories, Inc. | Pulmonary surfactant formulations |
GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
BRPI0613034A8 (pt) | 2005-07-14 | 2018-01-02 | Lipothera Inc | formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo. |
US20070293460A1 (en) * | 2005-10-31 | 2007-12-20 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
US20070098644A1 (en) * | 2005-10-31 | 2007-05-03 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
EP2077830B1 (en) * | 2006-10-17 | 2012-11-07 | Lithera, Inc. | Methods, compositions, and formulations for the treatment of thyroid eye disease |
EP2063940B1 (en) | 2006-12-22 | 2012-01-11 | Almirall, S.A. | Inhalation device for drugs in powder form |
EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
EP2327403A3 (en) | 2007-02-19 | 2011-08-31 | Cipla Limited | Pharmaceutical combinations of at least two bronchodilators |
EP1982709A1 (en) | 2007-04-19 | 2008-10-22 | CHIESI FARMACEUTICI S.p.A. | Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
WO2009026434A1 (en) * | 2007-08-21 | 2009-02-26 | Alkermes, Inc. | Pulmonary pharmaceutical formulations |
US20100291221A1 (en) * | 2009-05-15 | 2010-11-18 | Robert Owen Cook | Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation |
US9132084B2 (en) * | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
DK2435024T3 (en) | 2009-05-29 | 2016-10-24 | Pearl Therapeutics Inc | Compositions for the respiratory delivery of active agents and related methods and systems |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
CA2786618C (en) * | 2010-01-15 | 2016-04-12 | Lithera, Inc. | Lyophilized cake formulations |
CN102416179B (zh) | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
CN103269693A (zh) | 2010-11-24 | 2013-08-28 | 利赛拉公司 | 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法 |
US9730889B2 (en) * | 2011-05-09 | 2017-08-15 | University Of Houston System | Steroid-sparing effects of beta-adrenergic inverse agonists and uses thereof |
US11052202B2 (en) * | 2012-11-07 | 2021-07-06 | Chiesi Farmaceutici S.P.A. | Drug delivery device for the treatment of patients with respiratory diseases |
US20140275517A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
GB201321717D0 (en) * | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Inhalable Medicaments |
GB201408387D0 (en) * | 2014-05-12 | 2014-06-25 | Teva Pharmaceuticals Europ B V | Treatment of respiratory disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994974A (en) * | 1972-02-05 | 1976-11-30 | Yamanouchi Pharmaceutical Co., Ltd. | α-Aminomethylbenzyl alcohol derivatives |
SE378109B (ja) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
DE69002718T2 (de) * | 1989-09-08 | 1993-12-23 | Glaxo Group Ltd | Medikamente. |
IL95590A (en) * | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
-
1992
- 1992-12-07 PT PT92924683T patent/PT613371E/pt unknown
- 1992-12-07 ES ES92924683T patent/ES2172510T3/es not_active Expired - Lifetime
- 1992-12-07 SG SG1996008771A patent/SG48301A1/en unknown
- 1992-12-07 CA CA002123909A patent/CA2123909C/en not_active Expired - Lifetime
- 1992-12-07 DE DE2002199033 patent/DE10299033I2/de active Active
- 1992-12-07 WO PCT/EP1992/002826 patent/WO1993011773A1/en not_active Application Discontinuation
- 1992-12-07 NZ NZ246050A patent/NZ246050A/en unknown
- 1992-12-07 SK SK733-94A patent/SK282826B6/sk not_active IP Right Cessation
- 1992-12-07 AU AU30858/92A patent/AU673660C/en not_active Expired
- 1992-12-07 HU HU9401843A patent/HU227519B1/hu unknown
- 1992-12-07 DK DK92924683T patent/DK0613371T3/da active
- 1992-12-07 CA CA002356145A patent/CA2356145A1/en not_active Abandoned
- 1992-12-07 AT AT92924683T patent/ATE213946T1/de active
- 1992-12-07 SK SK489-2002A patent/SK285910B6/sk not_active IP Right Cessation
- 1992-12-07 DE DE69232462T patent/DE69232462T2/de not_active Expired - Lifetime
- 1992-12-07 HU HU0004452A patent/HU0004452D0/hu not_active Application Discontinuation
- 1992-12-07 CZ CZ19941434A patent/CZ288032B6/cs not_active IP Right Cessation
- 1992-12-07 JP JP51058593A patent/JP3342484B2/ja not_active Expired - Lifetime
- 1992-12-11 YU YU106192A patent/YU49083B/sh unknown
- 1992-12-17 IS IS3959A patent/IS3959A/is unknown
- 1992-12-18 HR HR921445A patent/HRP921445B1/xx not_active IP Right Cessation
- 1992-12-18 SI SI9200403A patent/SI9200403B/sl unknown
-
1994
- 1994-06-07 NO NO942116A patent/NO306452B1/no not_active IP Right Cessation
- 1994-10-03 US US08/317,407 patent/US5674860A/en not_active Expired - Lifetime
-
1997
- 1997-10-07 US US08/944,683 patent/US5972919A/en not_active Expired - Lifetime
-
1998
- 1998-10-14 HK HK98111237A patent/HK1010339A1/xx not_active IP Right Cessation
-
2000
- 2000-10-18 CZ CZ20003873A patent/CZ291455B6/cs not_active IP Right Cessation
-
2001
- 2001-07-31 NO NO2001014C patent/NO2001014I2/no unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002532418A (ja) * | 1998-12-18 | 2002-10-02 | ベーカー ノートン ファーマシューティカルズ インコーポレイテッド | フルオロアルカン、ブデソニド及びホルモテロールを含有する医薬用エアゾール製剤 |
JP2002537249A (ja) * | 1999-02-18 | 2002-11-05 | ノバルティス アクチエンゲゼルシャフト | 喘息のためのホルモテロールおよびプロピオン酸フルチカゾンの組み合わせ |
JP2010001295A (ja) * | 1999-03-03 | 2010-01-07 | Novartis Ag | 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ |
JP2013067668A (ja) * | 1999-03-03 | 2013-04-18 | Novartis Ag | 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ |
KR20210108500A (ko) * | 2013-12-09 | 2021-09-02 | 파르마헤미이 베이.베이. | 건조 분말 흡입기 |
JP2019500340A (ja) * | 2015-12-04 | 2019-01-10 | メキシケム フロー エセ・ア・デ・セ・ヴェ | 薬学的組成物 |
JP2020073515A (ja) * | 2015-12-04 | 2020-05-14 | メキシケム フロー エセ・ア・デ・セ・ヴェ | 薬学的組成物 |
JP2020073516A (ja) * | 2015-12-04 | 2020-05-14 | メキシケム フロー エセ・ア・デ・セ・ヴェ | 薬学的組成物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07502036A (ja) | 新規な配合 | |
EP0416951B1 (en) | Medicaments comprising salmeterol and fluticason | |
ES2342463T3 (es) | Formulacion superfina de formoterol. | |
US5208226A (en) | Medicaments | |
JP3042866B2 (ja) | 呼吸疾患治療薬 | |
JP2000502365A (ja) | 新規な組み合わせ | |
ES2319887T3 (es) | Formulacion superfina de salmeterol. | |
WO2000053187A1 (en) | New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd | |
AU2011307899B2 (en) | Compound composition for inhalation used for treating asthma | |
GB2235627A (en) | Inhalation medicaments | |
WO2000053188A1 (en) | New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd | |
EP0613371B1 (en) | New combination of formoterol and budesonide | |
JP2004500431A (ja) | (r,r)−ホルモテロール及びロフレポニドを含む医薬組成物 | |
TWI495466B (zh) | 用於氣喘之吸入性複方組合物 | |
KR100294834B1 (ko) | 호흡기질환치료용제약조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070823 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080823 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080823 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090823 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090823 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100823 Year of fee payment: 8 |
|
S202 | Request for registration of non-exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R315201 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100823 Year of fee payment: 8 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110823 Year of fee payment: 9 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110823 Year of fee payment: 9 |
|
R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110823 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120823 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130823 Year of fee payment: 11 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |